Board of Directors

Randy Teel, Ph.D.

Dr. Randy Teel serves as Arvinas President and Chief Executive Officer, as well as a member of the Company’s Board of Directors. He brings deep experience across corporate strategy, business development, and leadership in the biopharmaceutical industry. Prior to this role he served as Arvinas’ Chief Business Officer, overseeing corporate strategy, business development, investor relations, and communications, and played a key role in shaping the company’s long-term growth strategy, as well as instrumental roles in partnering and capital raising.

Before joining Arvinas, Dr. Teel was Vice President and Head of Strategy at Alexion Pharmaceuticals, where he led long-range planning and partnered closely with R&D and commercial organizations on inline and lifecycle management strategies. He also led enterprise risk management and numerous strategic initiatives across the company. Earlier in his career, Dr. Teel was an Associate Partner at McKinsey & Company, advising biopharmaceutical clients on commercial, medical, and operational strategy.

Dr. Teel holds a B.Sc. in Biology from Gonzaga University and a Ph.D. in Immunobiology from Yale University.